Why a $685 Million Insider Buy Ranked Only Sixth

Summary

The biggest insider purchase—roughly $685 million—ranked only sixth, showing why a large check can be far less important than valuation, growth, and cash generation. Intel finished eighth despite its CEO buying $10 million, because its roughly 59 times forward earnings multiple already assumes a major recovery. Alibaba ranked seventh: management invested more than $25 million, but negative $6.8 billion in reported free cash flow and heavy spending cloud the payoff. Republic Services took sixth as a dependable, recurring-revenue business, yet its roughly 29 times forward earnings valuation and 1.2% yield offer limited protection. Pfizer placed fifth, combining a yield above 6% with a multiple below 10, but slightly negative expected revenue and earnings growth weaken the case. Dick’s Sporting Goods ranked fourth after four directors bought roughly $3.7 million following an earnings shock; core comparable sales rose 4.9%, though reduced profit expectations leave turnaround risk. Vistra reached third because projected revenue and earnings growth of around 12% and 14% pair with a below-average valuation. Energy Transfer was the preferred income candidate, offering a roughly 6.3% to 6.4% distribution yield and positive operating growth, although its rally and higher historical valuation argue against chasing it. Boston Scientific ranked first conditionally: shares had fallen 49% year-to-date while forward revenue and earnings were still expected to grow around 10% and 11%. Its cybersecurity disruption must prove temporary before the apparent 21% margin of safety becomes compelling. The central lesson is to treat insider buying as a research signal, then demand that business performance and price independently justify an investment.